Press Release AMDL 2022 AMDL received certificate of CAP EQAP 2021 March 22, 2022 Read more » 2022 AMDL launched the Cancer Diagnostic Test February 22, 2022 Read more » 2021 Pillar Biosciences received premarket approval from FDA for its ONCO/Reveal™ Dx Lung and Colon Cancer Assay August 22, 2021 Read more » 2021 Renovation of molecular diagnostic laboratory in HKSTP finished January 22, 2020 Read more » 2019 China Biotech Services Holdings Limited and Pillar Biosciences entered into a strategic partnership January 22, 2019 Read more » Pillar Biosciences Pillar Biosciences Strengthens Leadership Team with Appointment of Vincent Ricci as Chief Financial Officer June 8, 2022 Readd more » Pillar Biosciences Announces Online Publication of Data in the Journal of Clinical Oncology May 31, 2022 Readd more » Pillar Biosciences Presents New Clinical Validation Data Confirming the Accuracy of its oncoReveal™ Dx Lung & Colon Cancer Assay in Detecting Clinically Relevant Variants April 11, 2022 Readd more » Pillar Biosciences Expands Leadership Team with Appointment of Daniel Harma as Chief Commercial Officer and Christa Adkins as General Counsel March 8, 2022 Readd more » Pillar Biosciences to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 10, 2022 Readd more » Pillar Biosciences Receives CLIA Certification for its Next-Generation Sequencing Clinical Laboratory January 6, 2022 Readd more »
